Allena pharmaceuticals, inc. (ALNA)
Balance Sheet / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Dec'16
Assets
Current assets:
Cash and cash equivalents

20,451

30,007

39,419

48,523

51,755

61,643

70,559

78,853

86,382

94,494

33,874

25,250

Short-term investments

-

-

-

-

-

-

-

-

-

-

-

23,505

Prepaid expenses and other current assets

2,316

3,028

2,160

3,726

1,316

2,826

2,178

911

962

1,539

577

520

Total current assets

22,767

33,035

41,579

52,249

53,071

64,469

72,737

79,764

87,344

96,033

34,451

49,275

Property and equipment, net

360

401

443

465

486

514

469

204

128

127

134

169

Operating lease assets

421

549

622

745

866

-

-

-

-

-

-

-

Deferred initial public offering costs

-

-

-

-

-

-

-

-

-

-

1,589

-

Other assets

123

123

123

123

390

246

191

96

96

89

89

35

Total assets

23,671

34,108

42,767

53,582

54,813

65,229

73,397

80,064

87,568

96,249

36,263

49,479

Liabilities and Stockholders’ Equity
Current liabilities:
Accounts payable

1,739

3,048

3,600

2,283

2,600

2,138

1,779

899

2,154

1,724

1,913

1,464

Loan payable, net of discount

3,992

3,992

2,992

1,992

992

-

-

-

3,870

3,870

3,066

176

Accrued expenses and other current liabilities

-

-

-

-

-

-

3,159

-

-

-

-

-

Accrued expenses and other current liabilities

1,864

3,370

3,367

2,887

2,670

3,625

-

1,826

1,222

1,949

2,159

1,610

Operating lease liabilities, net of discount

428

498

529

522

513

-

-

-

-

-

-

-

Total current liabilities

8,023

10,908

10,488

7,684

6,775

5,763

4,938

2,725

7,246

7,543

7,138

3,250

Loan payable, net of current portion and discount

4,990

5,988

6,986

7,984

8,982

9,980

9,977

9,979

4,537

5,516

6,620

9,409

Operating lease liabilities, net of current portion and discount

-

14

102

233

361

-

-

-

-

-

-

-

Warrants for the purchase of shares subject to redemption

-

-

-

-

-

-

-

-

-

-

460

267

Other liabilities

-

-

-

8

16

30

37

6

377

320

266

103

Total liabilities

13,013

16,910

17,576

15,909

16,134

15,773

14,952

12,710

12,160

13,379

14,484

13,029

Commitments and contingencies (Note 7)

-

-

-

-

-

-

0

0

0

-

0

0

Stockholders’ equity:
Common stock, $0.001 par value; 125,000,000 shares authorized; 24,742,146 and 24,735,009 shares issued and outstanding at March 31, 2020 and December 31, 2019, respectively

25

25

23

23

21

21

21

21

20

20

1

1

Additional paid-in capital

183,162

182,117

178,753

177,947

167,682

167,040

166,418

165,817

165,225

164,807

1,279

1,031

Accumulated other comprehensive loss

-

-

-

-

-

-

-

-

-

-

-

-2

Accumulated deficit

-172,529

-164,944

-153,585

-140,297

-129,024

-117,605

-107,994

-98,484

-89,837

-81,957

-75,280

-60,307

Total stockholders’ equity

10,658

17,198

25,191

37,673

38,679

49,456

58,445

67,354

75,408

82,870

-74,000

-59,277

Total liabilities and stockholders’ equity

23,671

34,108

42,767

53,582

54,813

65,229

73,397

80,064

87,568

96,249

36,263

49,479